IL208387A0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: IL208387A0
Authority: IL; Israel
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2008-04-04

Application number

IL208387A

Original Assignee

Robert Shorr

Robert Rodriguez

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-04

Filing date

2010-10-03

Publication date

2010-12-30

2010-10-03 Application filed by Robert Shorr, Robert Rodriguez filed Critical Robert Shorr

2010-12-30 Publication of IL208387A0 publication Critical patent/IL208387A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

IL208387A 2008-04-04 2010-10-03 Pharmaceutical composition IL208387A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/004410 WO2009123597A1 (en)	2008-04-04	2008-04-04	Pharmaceutical composition

Publications (1)

Publication Number	Publication Date
IL208387A0 true IL208387A0 (en)	2010-12-30

Family

ID=41135840

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL208387A IL208387A0 (en)	2008-04-04	2010-10-03	Pharmaceutical composition

Country Status (10)

Country	Link
EP (1)	EP2268278A4 (en)
JP (1)	JP2011516473A (en)
KR (1)	KR20110025168A (en)
CN (1)	CN102056605A (en)
AU (1)	AU2008354009A1 (en)
BR (1)	BRPI0821894A2 (en)
CA (1)	CA2720396A1 (en)
IL (1)	IL208387A0 (en)
MX (1)	MX2010010867A (en)
WO (1)	WO2009123597A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9980502B2 (en)	2010-07-08	2018-05-29	Wm. Wrigley Jr. Company	Chewing gum containing a cross-linked gelatin matrix gum base
US9421234B2 (en) *	2011-05-20	2016-08-23	Nutramax Laboratories, Inc.	Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
JP6253596B2 (en) *	2012-02-16	2017-12-27	ザペンステイトリサーチファンデーション	Acyl coenzyme A: a method for identifying an inhibitor of expression, function or activity of lysocardiolipin acyltransferase 1 (ALCAT1)
CA2895029A1 (en) *	2012-12-19	2014-06-26	Robert Shorr	Metal complexes of lipoic acid derivatives
WO2015195070A1 (en)	2014-06-19	2015-12-23	Robert Shorr	Pharmaceutical compounds
EP3188726B1 (en)	2014-06-19	2019-08-07	Rafael Pharmaceuticals, Inc.	Pharmaceutical compounds
CN110590624B (en) *	2019-09-26	2021-02-26	苏州富士莱医药股份有限公司	Preparation method of lipoic acid derivative 8- (ethyl disulfide) -6- (phenyl disulfide) caprylic acid
WO2023012305A1 (en) *	2021-08-04	2023-02-09	Cytacoat Ab	Disulfide compounds as medicaments

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2853497A (en) *	1953-12-04	1958-09-23	Merck & Co Inc	6, 8-bis (hydrocarbon substituted mercapto) 5-hydroxycaprylic acids and delta-lactones thereof
US2789991A (en) *	1954-05-20	1957-04-23	American Cyanamid Co	Substituted disulfones
JPS61198148A (en) *	1985-01-29	1986-09-02	Fuji Photo Film Co Ltd	Silver halide photographic sensitive material
GB9618934D0 (en) *	1996-09-11	1996-10-23	Univ London	Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
CA2487328A1 (en) *	1998-03-20	1999-09-30	Benitec Australia Ltd.	Sirna for control of gene expression
FR2777001B1 (en) *	1998-04-01	2000-06-09	Cird Galderma	6,8-DIMERCAPTOOCTANOIC ACID DERIVATIVES SUBSTITUTED IN 6-S AND / OR 8-S BY RADICAL (3-METHYLTHIOPROPANOYL) AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER TUMORS
IL142824A0 (en) *	1998-10-26	2002-03-10	Univ New York State Res Found	Lipoic acid derivatives and their use in treatment of disease
DE19904794A1 (en) *	1999-02-05	2000-08-10	Biotechnolog Forschung Gmbh	Methods for improving the primary metabolism of mammalian cell lines
US6284786B1 (en) *	1999-02-16	2001-09-04	The Center For The Improvement Of Human Functioning, Int'l., Inc.	Treatment of cancer using lipoic acid in combination with ascorbic acid
AR042572A1 (en) *	1999-04-02	2005-06-29	Sod Conseils Rech Applic	DERIVATIVES OF LIPOIC ACID, PROCEDURE FOR THE PREPARATION, MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF SUCH DERIVATIVES FOR THE PREPARATION OF THE REFERRED MEDICATIONS
IT1312060B1 (en) *	1999-04-09	2002-04-04	Antibioticos Spa	USE OF ALPHA LIPOIC ACID IN ANTIMETASTATIC TREATMENT.
US7108977B2 (en) *	2000-05-19	2006-09-19	Hoffmann-La Roche Inc.	Process for determining the tumoricidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells
WO2006119355A2 (en) *	2005-05-03	2006-11-09	Albert Einstein College Of Medicine Of Yeshiva University	Mammalian hypothalamic nutrient modulation of glucose metabolism
US20070077583A1 (en) *	2005-09-21	2007-04-05	Aurelium Biopharma, Inc.	Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
US20070212360A1 (en) *	2006-01-17	2007-09-13	Denko Nicholas C	Modulation of mitochondrial oxygen consumption for therapeutic purposes
NZ580973A (en) *	2007-04-18	2011-10-28	Cornerstone Pharmaceuticals Inc	Pharmaceutical formulations containing lipoic acid derivatives
EP2695614B1 (en) *	2007-04-18	2017-07-05	Cornerstone Pharmaceuticals, Inc.	Lipoic acid derivatives
KR20110004846A (en) *	2008-03-04	2011-01-14	로버트 쇼어	Modulation of enzymatic structure, activity, and/or expression level

2008
- 2008-04-04 WO PCT/US2008/004410 patent/WO2009123597A1/en active Application Filing
- 2008-04-04 MX MX2010010867A patent/MX2010010867A/en not_active Application Discontinuation
- 2008-04-04 EP EP08742562A patent/EP2268278A4/en not_active Withdrawn
- 2008-04-04 AU AU2008354009A patent/AU2008354009A1/en not_active Abandoned
- 2008-04-04 CN CN2008801296335A patent/CN102056605A/en active Pending
- 2008-04-04 KR KR1020107024775A patent/KR20110025168A/en not_active Application Discontinuation
- 2008-04-04 BR BRPI0821894-3A patent/BRPI0821894A2/en not_active IP Right Cessation
- 2008-04-04 JP JP2011502908A patent/JP2011516473A/en active Pending
- 2008-04-04 CA CA2720396A patent/CA2720396A1/en not_active Abandoned
2010
- 2010-10-03 IL IL208387A patent/IL208387A0/en unknown

Also Published As

Publication number	Publication date
WO2009123597A1 (en)	2009-10-08
EP2268278A4 (en)	2011-11-09
BRPI0821894A2 (en)	2015-07-21
AU2008354009A1 (en)	2009-10-08
EP2268278A1 (en)	2011-01-05
KR20110025168A (en)	2011-03-09
CA2720396A1 (en)	2009-10-08
JP2011516473A (en)	2011-05-26
CN102056605A (en)	2011-05-11
MX2010010867A (en)	2011-05-25

Publication	Publication Date	Title
HUS1800007I1 (en)	2018-03-28	Pharmaceutical composition
IL228817A0 (en)	2013-12-31	Pharmaceutical composition
EP2240022A4 (en)	2012-04-25	Pharmaceutical compositions
GB0814695D0 (en)	2008-09-17	Pharmaceutical compositions
EP2133095A4 (en)	2012-09-26	Pharmaceutical composition
EP2133094A4 (en)	2010-10-13	Pharmaceutical composition
EP2191826A4 (en)	2010-09-15	Pharmaceutical composition
EP2373681A4 (en)	2013-11-06	Pharmaceutical compositions
PL2323623T3 (en)	2017-04-28	Pharmaceutical compositions
IL200125A0 (en)	2010-04-15	Pharmaceutical composition
EP2236149A4 (en)	2012-12-26	Medicinal composition
EP2224805A4 (en)	2013-10-16	Pharmaceutical composition
EP2224915A4 (en)	2014-01-22	Pharmaceutical composition
ZA201102715B (en)	2012-07-25	Solid pharmaceutical composition
IL208387A0 (en)	2010-12-30	Pharmaceutical composition
HK1138774A1 (en)	2010-09-03	Pharmaceutical composition
EP2224808A4 (en)	2013-11-27	Pharmaceutical composition
ZA201100871B (en)	2012-05-30	Solid pharmaceutical composition
EP2156832A4 (en)	2010-11-24	Pharmaceutical composition
ZA201006224B (en)	2011-11-30	Pharmaceutical composition
EP2327406A4 (en)	2014-04-09	Stabilized pharmaceutical composition
EP2224806A4 (en)	2014-02-19	Pharmaceutical composition
GB2464200B (en)	2013-05-08	Pharmaceutical composition
GB0817969D0 (en)	2008-11-05	Pharmaceutical composition
IL206487A0 (en)	2010-12-30	Pharmaceutical compositions